Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.

A New Target for CAR-T Therapies

Researchers at the National Cancer Institute have identified a second protein on cancer cells that could be used as a target for CAR-T therapies in the future

Juno’s CAR-T Therapy Trial Deaths

Juno Therapeutics reveals the main conclusions of their investigation into the deaths of five patients involved in the company’s CAR-T clinical trial, ROCKET, last year